Research Associate, Enzymology
Abingdon, Oxfordshire
We are looking for a research associate to support the pivotal functions of the UK biochemical screening and mechanistic enzymology group.
Vertex Pharmaceuticals Europe Ltd brings together scientists of multiple disciplines and various backgrounds to form a highly creative and productive team. Our scientists work in an environment where chemists, biologists, structural biologists and computational chemists focus together on cancer and inflammatory diseases. Our research facility in Oxfordshire is equipped with the latest technology and through collaboration with the wider organisation our world class teams are tackling the most ambitious projects in the industry.
You will be responsible for generating inhibition data for test compounds in support of drug discovery, using a variety of manual and automated assay formats (e.g radiometric, spectrophotometric, fluorometric, direct binding), as well as supporting the day-to-day compound-management function of the UK site. Other roles and responsibilities may include characterising enzyme kinetics and inhibitor mode-of-action, and supporting the high-throughput screening activities of the group.
We are looking for candidates with strong communication and time management skills, who are comfortable working to stringent protocols and are capable of working independently as part of a busy and highly motivated team. You will have a scientific background, preferably with a degree in a relevant discipline, strong mathematical skills and experience of working in a drug discovery laboratory environment.
To apply for this role please click the apply Button
Closing date for applications is Friday 27 July 2012.
The Science of Possibility.
Vertex creates new possibilities in medicine. Our team aims to discover and develop innovative therapies so people with serious diseases can lead better lives. Vertex scientists and our collaborators are working on new medicines to cure or significantly advance the treatment of hepatitis C, cystic fibrosis, epilepsy and other life-threatening diseases. Founded more than 20 years ago in Cambridge, MA, we now have ongoing worldwide research programs and sites in the U.S., U.K. and Canada.